Synthesis and Antitumor Evaluation of a Novel Class of Chalcone Mannich Base Derivatives

5Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Your institution provides access to this article.

Abstract

A novel class of chalcone Mannich base derivatives I1-9 and II1-11 was synthesized, which exhibited significant antiproliferation activities in five different cancer cells. The activities of most compounds were superior to those of the positive control drug 5-FU. Moreover, compared with the intermediate chalcone, their water solubility was also significantly enhanced. Among them, the most prospective compound I4 (IC50 = 3.09–5.08 μM for the tested cancer cells) can effectively inhibit the proliferation of A549/DDP cells (IC50 = 4.69 μM). Further mechanistic studies revealed that it can induce apoptosis of A549 and A549/DDP cells by arresting the G2/M phase of the cell cycle. Although the selectivity of compound I4 between tumor cells and normal cells was not obvious, it might be a promising lead compound for lung cancer and is worthy of further investigation.

Cite

CITATION STYLE

APA

He, B., Tan, H. zhou, Liu, C. bo, Wu, H., & He, L. qin. (2025). Synthesis and Antitumor Evaluation of a Novel Class of Chalcone Mannich Base Derivatives. Chemical Biology and Drug Design, 105(3). https://doi.org/10.1111/cbdd.70079

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free